Alternative renin regulatory pathways and the NKCC1 isoform

William H. Beierwaltes

Hypertension and Vascular Research Division, Henry Ford Hospital and Health Sciences Center, Detroit, Michigan

THE MACULA DENSA IS ONE OF the classic regulatory pathways that control the release of renin from the juxtaglomerular cells (11). It senses the distal luminal NaCl concentration in the thick ascending limb and sends a signal to increase renin secretion in response to sustained decreases in distal NaCl delivery. In 1968–1969, shortly after the development and availability of loop diuretics, investigators began reporting their ability to stimulate renin secretion in humans (10), rats (1), rabbits (9), and dogs (13). It was generally thought that the diuretic-induced diuresis resulted in decreased plasma volume and therefore stimulation of the renal baroreceptor and sympathetic nervous system, and that prolonged natriuresis would ultimately lead to stimulation of renin secretion by the juxtaglomerular (JG) cells (7). We now appreciate that these diuretics act through inhibition of the (furosemide-sensitive) Na+-K+-2Cl cotransporter (NKCC2) in the macula densa (11), likely resulting in activation of a cascade that involves stimulation of cyclooxygenase-2 (5) in the macula densa, resulting in the formation of PGE2, which interacts with the adjacent JG cells (12) to stimulate adenylate cyclase, and formation of the potent second messenger for renin, cAMP. Each of these components seems to be discretely located within this pathway, including the unique expression of NKCC2 within the apical membrane of the thick ascending limb and macula densa (14). Thus the anatomic localization of the NCCC2 isoform to the macula densa leads predictably to the dogma that it is solely responsible for initiating the cascade. However, as the study by Castrop et. al (2) suggests, things are not always as simple as we would like to think. While the NKCC2 isoform is located in the macula densa, loop diuretics are not selective enough to discriminate between the two isoforms of the cotransporter. Thus these authors decided to examine the possible role of the NKCC1 isoform as a partial mediator of the renin response to loop diuretics. In the absence of isoform-selective drugs, the development of an NKCC1 knockout mouse (3, 8) provided a unique opportunity to test their novel hypothesis. The NKCC1 isoform of this member of the cation cotransporter superfamily is widely distributed in secretory epithelia and generally thought to be involved in controlling cellular volume, often coordinating with other cellular ionic pumps, as well as chloride excretion (4). In the kidney, the NKCC1 isoform has been reported to exist in cortical locations near the JG cells, including the afferent arterioles and the glomerular and extraglomerular mesangium (3), where it could easily respond to changes in plasma or even distal tubular salt composition.

Castrop et al. (2) report that basal circulating renin levels were increased in the NKCC1 knockouts, as were renin mRNA and the percentage of microdissected afferent arterioles that stained for renin or renin recruitment. Furosemide inhibition of NKCC cotransport in vivo stimulated renin in both strains of mice; however, in a primary culture of isolated JG cells, only those from wild-type mice (with NKCC1 intact) showed a 10% increase in membrane capacitance, and therefore, by implication, a stimulus for renin in response to furosemide could be mediated by NKCC1 on the JG cells (something not previously demonstrated). With the chronic absence of NKCC1 in the knockouts, every parameter of renin (plasma renin concentration, mRNA, histological distribution, in vitro stimulation) seemed to be exaggerated, suggesting that in the knockouts some tonic suppression of renin had been deleted. Thus while the authors' initial hypothesis that NKCC1 could also mediate the classic macula densa pathway was not supported, they do reveal an important modulating effect of this transporter on the process of renin regulation. Their observations represent a new and unexpected pathway that may influence renin secretion.

As exciting and provocative as this observation is, some cautions are in order. First, the remarkable technology of gene deletion is not without its limitations. These mice often adapt by developing redundant or back-up systems to compensate for the lost expression. Importantly, systemic blood pressure in NKCC1 knockouts may be lower (8), which could lead to chronic stimulation of renin through the renal baroreceptor, independently of a direct effect of NKCC1 on the JG cell. This provides a certain irony, as it would support the original hypothesis of the 1960s that the effect of loop diuretics on renin was secondary to some degree of volume depletion influencing the renal baroreceptor (7). As pointed out by Castrop et al. (2), "these in vivo experiments do not permit a clear distinction between direct and indirect consequences of the NKCC1 null mutation on the renin-angiotensin system." However, the combination of data from these in vivo studies and their primary cultures of isolated JG cells from both wild-type and knockout mice supports their conclusion that there may be a tonic influence of the cotransporter. Ultimately, the NKCC1 isoform is rather ubiquitous, and thus its deletion may have important consequences, perhaps even uncovering various aspects of its involvement in renal function including chloride excretion (3), renal vascular resistance, and renal perfusion (8). The final answers to the question of how NKCC1 modulates renal function and specifically renin secretion will probably involve various direct and indirect signals under different conditions. The resolution of this question will unfold because of the novel model, not even dreamed of in the 1960s when this journey began, and the unorthodox thinking of these investigators who are willing to test ideas that confront and challenge convention.


    FOOTNOTES
 

Address for reprint requests and other correspondence: W. H. Beierwaltes, Hypertension and Vascular Research Div., Henry Ford Hospital and Health Sciences Ctr., E and R Bldg., 2799 W. Grand Blvd., Detroit, MI 48202-2689


    REFERENCES
 TOP
 REFERENCES
 

  1. Burgoignie JJ, Catanzaro FJ, and Perry HM Jr. Renin-angiotensin-aldosterone system during chronic thiazide therapy of benign hypertension. Circulation 27: 27–35, 1968.
  2. Castrop H, Lorenz JN, Hansen P, Friis U, Mizel D, Oppermann M, Jensen B, Briggs J, Skøtt O, and Schnermann J. Contribution of the basolateral isoform of the Na-K-2Cl cotransporter (NKCC1/BSC2) to renin secretion. Am J Physiol Renal Physiol 289: F1185–F1192, 2005.
  3. Flagella M, Clarke LL, Miller ML, Erway LC, Giannella RA, Andringa A, Gawenis LR, Kramer J, Duffy JJ, Doetschman T, Lorenz JN, Yamoah EN, Cardell EL, and Shull GE. Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem 274: 26946–26955, 1999.[Abstract/Free Full Text]
  4. Haas M and Forbush B. The Na-K-Cl cotransporter of secretory epithelia. Annu Rev Physiol 62: 515–534, 2000.[CrossRef][ISI][Medline]
  5. Harris RC, McKenna JA, Akai Y, Jacobson HR, Doubois RN, and Breyer MD. Cyclooxygenase-2 is associated with the macula densa of the rat kidney and increases with salt restriction. J Clin Invest 94: 2505–2510, 1994.
  6. Kaplan MR, Plotkin MD, Brown D, Hebert SC, and Delpire E. Expression of the mouse Na-K-Cl cotransporter, mBSC2, in the terminal inner medullary collecting duct, glomerular and extraglomerular mesangium and the glomerular afferent arteriole. J Clin Invest 98: 723–730, 1996.[Abstract/Free Full Text]
  7. Keeton TK and Campbell WB. The pharmacologic alteration of renin release. Pharm Rev 32: 81–227, 1980.[Free Full Text]
  8. Meyer JW, Flagella M, Sutliff RL, Lorenz JN, Nieman ML, Weber CS, Paul RJ, and Shull GE. Decreased blood pressure and vascular smooth muscle tone in mice lacking basolateral Na-K-2Cl cotransporter. Am J Physiol Heart Circ Physiol 283: H1846–H1855, 2002.[Abstract/Free Full Text]
  9. Meyer P, Menard J, Papanicolaou N, Alexander JM, Devaux C, and Millez P. Mechanism of renin release following furosemide diuresis in rabbits. Am J Physiol 215: 908–915, 1968.[Free Full Text]
  10. Rosenthal J, Boucher R, Nowaczynski W, and Genest J. Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following furosemide administration. Can J Physiol Pharmacol 46: 85–91, 1968.[ISI][Medline]
  11. Schlatter E, Salomonson M, Persson AEG, and Greger R. Macula densa cells sense luminal NaCl concentration via furosemide-sensitive Na+- 2Cl-K+ cotransport. Pflügers Arch 414: 286–290, 1989.[CrossRef][ISI][Medline]
  12. Traynor TR, Smart A, Briggs JP, and Schnermann J. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2. Am J Physiol Renal Physiol 277: F706–F710, 1999.[Abstract/Free Full Text]
  13. Vander AJ and Carlson J. Mechanism of the effects of furosemide on renin secretion in anesthetized dogs. Circ Res 25: 145–152, 1969.[Abstract/Free Full Text]
  14. Yang T, Huang YG, Singh I, Schnermann J, and Briggs JP. Localization of bumetanide- and thiazide-sensitive Na-K-Cl cotransporters along the rat nephron. Am J Physiol Renal Fluid Electrolyte Physiol 271: F931–F939, 1996.[Abstract/Free Full Text]




This Article
Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Beierwaltes, W. H.
PubMed
PubMed Citation
Articles by Beierwaltes, W. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.